Nordic Capital to buy Advanz Pharma

Nordic Capital has agreed to acquire Advanz Pharma Corp, a specialty pharmaceutical company focused on complex medicines in Europe.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this